News for SciSparc Ltd. (SPRCY)

TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ( SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing

Clearmind Medicine (CMND) has reached a crucial milestone with the publication of its European patent application by the European Patent Office. This patent, id

Patent publication in Europe strengthens Clearmind's global IP position and advances strategic focus on addiction treatment Vancouver, Canada, May 12, 2025 (

\n SciSparc Ltd. (SPRC) collaborates with Clearmind Medicine Inc. on an innovative addiction treatment. The partnership focuses on a patent application in

SciSparc Ltd. (SPRC) has joined forces with Clearmind Medicine to file an international patent application for a novel treatment targeting eating disorders such

**media[605557]**

Vancouver, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CMND), (FSE: CWY0) (”œClearmind” or the "Company"), a clinical-stage biote

TEL AVIV, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ( SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company f

**media[555553]**

TEL AVIV, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ( SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company fo

Neve Yarak, Israel, Feb. 26, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.\ ( NITO) (FSE:80W) (”œN2OFF” and the ”œCompany”), a clean tech company engaged in sust

February 14, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to wat...

No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares TEL AVIV, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ( SPRC)

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ( SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.04%

January 6, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including bi...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday. The Dow traded up 0.08% to 42,765.84 whi...

U.S. stocks traded higher midway through trading, with the S&P 500 jumping more than 1% on Monday. The Dow traded up 0.51% to 42,949.22 while the NASDAQ gained...